Sarah Jessica Parker severs ties with EpiPen maker over price increase

ACTOR Sarah Jessica Parker has ‘ended her relationship’ with Mylan, the company that produces EpiPens, after it increased the price of the lifesaving drug.

Sarah Jessica Parker says she is ”disappointed, saddened and deeply concerned” by the price hike of the EpiPen. She has cut ties with the company that makes the emergency allergy treatment. Picture: Charles Sykes/Invision/AP

SAYING she is “disappointed, saddened and deeply concerned” by the price hike of the EpiPen, actor Sarah Jessica Parker has cut ties with the company that makes the emergency allergy treatment.

Parker, whose 13-year-old son James has severe peanut and hazelnut allergies, was part of a short campaign with pharmaceutical giant Mylan N.V., maker of the EpiPen. She was never a spokeswoman.

Actor Sarah Jessica Parker with her son James Wilke Broderick in 2010.

Matthew Broderick and Sarah Jessica Parker pose with their son James Broderick in 2011. Picture: Stephen Lovekin/Getty Images

The company is facing heated criticism about the average cost of the EpiPen climbing more than 600 per cent over the past decade. Parker took to Instagram on Thursday to distance herself from the company and urged it to “take swift action to lower the cost to be more affordable for whom it is a lifesaving necessity.” A representative for the actor confirmed the statement was accurate.